文献速递重症综合管理与镇静镇痛

评估CD69、CD64和CD25作为小鼠脓毒症生物标志物的及时性与特异性

Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice.
PubMed 文献 · Shock · 2021-01-01
一句话结论小鼠模型中CD69能特异性区分脓毒症,CD64和CD25在假手术后短暂升高;最佳标志物或组合取决于检测时机、小鼠年龄和手术因素。

本研究在盲肠结扎穿刺和盲肠浆液两种小鼠脓毒症模型中,评估CD69、CD64和CD25作为脓毒症生物标志物的及时性与特异性。荧光激活细胞分选分析显示,三种标志物在脓毒症时血白细胞上均升高;CD69为脓毒症特异性上调,而CD64和CD25在假手术后也短暂升高。最佳标志物或组合取决于检测时机、小鼠年龄和手术因素;CD69区分脓毒症能力优秀,某些场景下CD69联合CD64可提升诊断性能。微流控分析中CD64可区分脓毒症小鼠与 naive 对照。作者认为CD69和CD64是有价值的小鼠脓毒症快速检测标志物,小鼠模型可用于研究和验证脓毒症标志物。

要点

  • 小鼠脓毒症模型中CD69在血白细胞上特异性上调,而CD64和CD25在假手术后也短暂升高。
  • 最佳标志物或组合取决于检测时机、小鼠年龄和是否经历手术。
  • CD69区分脓毒症能力优秀,某些场景下CD69联合CD64可增强诊断性能。
  • 微流控分析中CD64可区分脓毒症小鼠与naive对照。
  • 作者认为CD69和CD64是有价值的小鼠脓毒症快速检测标志物,小鼠模型可用于研究和验证脓毒症标志物。

适用人群与场景

  • 年轻和老年小鼠,采用盲肠结扎穿刺和盲肠浆液两种脓毒症模型。

研究设计与关键结果

  • 荧光激活细胞分选分析显示,脓毒症时三种标志物在血白细胞上均升高;CD69为脓毒症特异性上调,CD64和CD25在假手术后也短暂升高。
  • 最佳标志物或组合取决于检测时机、小鼠年龄和手术因素;CD69区分脓毒症能力优秀,某些场景下CD69联合CD64可增强诊断性能。
  • 微流控分析中CD64可区分脓毒症小鼠与naive对照。
  • 作者认为CD69和CD64是有价值的小鼠脓毒症快速检测标志物,小鼠模型可用于研究和验证脓毒症标志物。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis occurs when an infection induces a dysregulated immune response, and is most commonly bacterial in origin. This condition requires rapid treatment for successful patient outcomes. However, the current method to confirm infection (blood culture) requires up to 48 h for a positive result and many true cases remain culture-negative. Therefore, new diagnostic tests are urgently needed. Recent clinical studies suggest that CD69, CD64, and CD25 may serve as useful biomarkers of sepsis. In this study, we evaluated the cecal ligation and puncture and cecal slurry mouse models as tools to study these biomarkers in young and aged mice, and elucidate the timeliness and specificity of sepsis diagnosis. Fluorescence-activated cell sorting analysis revealed that all three biomarkers were elevated on blood leukocytes during sepsis. CD69 was specifically upregulated during sepsis, while CD64 and CD25 were also transiently upregulated in response to sham surgery. The optimal biomarker, or combination of biomarkers, depended on the timing of detection, mouse age, and presence of surgery. CD69 demonstrated an excellent capacity to distinguish sepsis, and in some scenarios the diagnostic performance was enhanced by combining CD69 with CD64. We also analyzed biomarker expression levels on specific cell populations (lymphocytes, monocytes, and neutrophils) and determined the cell types that upregulate each biomarker. Elevations in blood biomarkers were also detected via microfluidic analyses; in this case CD64 distinguished septic mice from naive controls. Our results suggest that CD69 and CD64 are valuable biomarkers to rapidly detect sepsis, and that mouse models are useful to study and validate sepsis biomarkers.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Goswami DG, Garcia LF, Dodoo C, et al. Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice. Shock. 2021. PMID: 32890312. doi:10.1097/SHK.0000000000001650

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。